Brillion Eyecare, LLC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Brillion Eyecare, LLC

Sort by

Viewing results 1‒13 of 13

US & Canadian companies
Geithner to take strategy role at Warburg Pincus
...Warburg Pincus has $35bn of assets under management, with investments spanning Bausch & Lomb, the eyecare company, and Poundland, the UK retailer....
November 16, 2013
US & Canadian companies
Valeant nears $9bn Bausch & Lomb deal
...Bausch & Lomb, a leading eyecare maker owned by private equity firm Warburg Pincus, has been considering a sale or public offering since late last year....
May 24, 2013
FT Live
Financial Adviser Service Awards 2024
Who gives you 5 star service?
Thursday, 21 NovemberNatural History Museum, Cromwell Road, London, UK
US & Canadian companies
Bausch & Lomb: successful outcome
...Actavis itself was a target of Valeant Pharmaceuticals but after the Actavis/Warner Chilcott tie-up, Valeant fixed its gaze on eyecare company Bausch & Lomb, to the delight of Warburg Pincus....
May 27, 2013
LexUS & Canadian companies
Bausch & Lomb – profit focus
...Private equity firm Warburg Pincus reportedly hopes to sell Bausch & Lomb for $10bn; it paid $4.5bn for the eyecare group in 2007....
December 14, 2012
US & Canadian companies
Buyout groups try IPO discounting
...Other private-equity backed companies that recently filed or may soon do so include Aleris, an aluminium company; Bausch & Lomb, the eyecare company; Evertec, a payment processing company; Pinnacle Foods...
February 27, 2013
US & Canadian companies
Bausch & Lomb put up for sale at $10bn
...Before that deal, the eyecare specialist had hit by a series of setbacks involving the recall of faulty products and restatements of earnings....
December 12, 2012
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
US & Canadian companies
US M&A activity defies European headwinds
...Meanwhile, Valeant, the acquisitive speciality pharmaceutical group, made public its interest in eyecare specialist ISTA Pharmaceuticals, offering $6.50 a share in cash, or about $314m, for the company having...
December 16, 2011
LexUK companies
AstraZeneca
...Rather than move into dermatology treatments, like GSK, or eyecare, like Novartis, AZ wants to make up for a dearth of promising new drugs by improving research and development. That is risky....
April 23, 2009
US & Canadian companies
Proxy advisers back Bausch & Lomb bid
...Bausch & Lomb, the US eyecare company, on Friday said it had gained the support of four leading proxy advisory firms for its all-cash $3.7bn sale to Warburg Pincus, the US private equity group....
September 14, 2007
US & Canadian companies
Banks to sell First Data loan at discount
...■ Bausch & Lomb, the US eyecare company, said it had gained the support of four leading proxy advisory firms for its all-cash $3.7bn sale to Warburg Pincus, the US private equity group....
September 14, 2007
FT AlphavilleGwen Robinson
… As AMO’s Bausch & Lomb bid suffers blow
...Advanced Medical Optics’ $5bn counterbid for rival US eyecare company Bausch & Lomb was dealt a blow on Wednesday, when ValueAct Capital, one of its largest shareholders, unexpectedly said the move was too...
July 12, 2007
US & Canadian companies
ValueAct denies Bausch & Lomb u-turn
...But people close to the California-based eyecare group said ValueAct had met and discussed teaming up to bid for Bausch & Lomb on three occasions: May 24, June 12, and July 5....
July 12, 2007
Retail & Consumer industry
Bausch & Lomb bid suffers blow
...Advanced Medical Optics’ $5bn counterbid for rival US eyecare company Bausch & Lomb was dealt a blow on Wednesday, when ValueAct Capital, one of its largest shareholders, unexpectedly said the move was too...
July 11, 2007

Previous pagePage 1 of 1Next page